Then, in 2006, the 32-year-old from Jersey City enrolled in a clinical trial for ustekinumab, a then-experimental biologic medication for psoriasis that has since been approved by the U.S. Food and Drug Administration (FDA) under the name Stelara.
Also know, when was Stelara Approved for Crohn's?
Development History and FDA Approval Process for Stelara
Date | Article |
Sep 26, 2016 | FDA Approves Stelara (ustekinumab) for Treatment of Adults with Moderately to Severely Active Crohn's Disease |
Sep 23, 2013 | Stelara (ustekinumab) Receives FDA Approval to Treat Active Psoriatic Arthritis |
Also to know, is Stelara approved for ulcerative colitis?
Stelara Approved for Moderately to Severely Active Ulcerative Colitis. The Food and Drug Administration (FDA) has approved Stelara (ustekinumab; Janssen) for the treatment of adult patients with moderately to severely active ulcerative colitis.
What is Stelara approved for?
STELARA® is indicated for the treatment of patients 12 years or older with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. STELARA® is indicated for the treatment of adult patients with active psoriatic arthritis.
Does stelara lower your immune system?
Stelara can affect your immune system and can lower your body's ability to fight an infection.